LEVETIRACETAM

LEVETIRACETAM was reported 135096 times

LEVETIRACETAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE-DRUG RESISTANCE 1506 0.4852
1 POSTICTAL PSYCHOSIS 73 0.4679
2 EPILEPTIC ENCEPHALOPATHY 98 0.4395
3 CHANGE IN SEIZURE PRESENTATION 233 0.3601
4 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 185 0.3458
5 FOCAL DYSCOGNITIVE SEIZURES 393 0.3450
6 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 148 0.3162
7 PSYCHOGENIC SEIZURE 283 0.3027
8 VAGAL NERVE STIMULATOR IMPLANTATION 89 0.2908
9 SEIZURE CLUSTER 241 0.2907
10 MYOCLONIC EPILEPSY 433 0.2852
11 POSTICTAL PARALYSIS 68 0.2810
12 PARTIAL SEIZURES 1466 0.2797
13 STATUS EPILEPTICUS 2946 0.2606
14 EPILEPTIC AURA 67 0.2597
15 ATONIC SEIZURES 203 0.2363
16 INFANTILE SPASMS 169 0.2337
17 COMPLEX PARTIAL SEIZURES 249 0.2239
18 SIMPLE PARTIAL SEIZURES 178 0.2206
19 PETIT MAL EPILEPSY 1068 0.2090
20 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 135 0.2077
21 AURA 371 0.1987
22 TEMPORAL LOBE EPILEPSY 86 0.1968
23 ANTICONVULSANT DRUG LEVEL DECREASED 263 0.1861
24 GENERALISED TONIC-CLONIC SEIZURE 3023 0.1825
25 TONIC CONVULSION 255 0.1798
26 ANTICONVULSANT DRUG LEVEL INCREASED 283 0.1751
27 DRUG WITHDRAWAL CONVULSIONS 301 0.1691
28 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 126 0.1673
29 PROPOFOL INFUSION SYNDROME 104 0.1475
30 SEIZURE 16242 0.1405
31 EPILEPSY 4201 0.1373
32 GLIOBLASTOMA MULTIFORME 114 0.1354
33 DEVELOPMENTAL HIP DYSPLASIA 100 0.1202
34 BEHAVIOUR DISORDER 609 0.1125
35 BREAST FEEDING 86 0.1101
36 BRAIN OPERATION 246 0.1077
37 ENCEPHALITIS AUTOIMMUNE 140 0.1065
38 POLYDACTYLY 123 0.1060
39 FOETAL MALFORMATION 114 0.1049
40 CLONIC CONVULSION 76 0.1038
41 ELECTROENCEPHALOGRAM ABNORMAL 321 0.1016
42 CRYPTORCHISM 112 0.0997
43 HYPERAMMONAEMIC ENCEPHALOPATHY 171 0.0983
44 GLIOBLASTOMA 166 0.0972
45 POSTICTAL STATE 96 0.0924
46 CEREBELLAR ATROPHY 81 0.0919
47 INTELLECTUAL DISABILITY 139 0.0915
48 FEBRILE CONVULSION 100 0.0820
49 GRAND MAL CONVULSION 755 0.0817
50 PARADOXICAL DRUG REACTION 294 0.0798
51 HYPERAMMONAEMIA 385 0.0769
52 SELECTIVE EATING DISORDER 68 0.0747
53 STILLBIRTH 353 0.0730
54 CONVULSION 4083 0.0713
55 HYPOSPADIAS 146 0.0701
56 DYSMORPHISM 163 0.0691
57 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 398 0.0671
58 CLEFT LIP AND PALATE 75 0.0671
59 SPINA BIFIDA 138 0.0662
60 BRADYCARDIA NEONATAL 83 0.0660
61 CYTOGENETIC ABNORMALITY 74 0.0655
62 EXCESSIVE EYE BLINKING 95 0.0642
63 CLEFT PALATE 120 0.0620
64 ATAXIA 725 0.0610
65 PREGNANCY 1217 0.0607
66 SMALL FOR DATES BABY 292 0.0588
67 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 130 0.0581
68 APLASTIC ANAEMIA 303 0.0580
69 MICROCEPHALY 74 0.0577
70 MYOCLONUS 685 0.0574
71 RESPIRATORY DISORDER NEONATAL 93 0.0573
72 TRISOMY 21 69 0.0548
73 GAZE PALSY 92 0.0540
74 HYPOTONIA NEONATAL 84 0.0537
75 NEUROLOGICAL DECOMPENSATION 123 0.0531
76 CONGENITAL ANOMALY 407 0.0525
77 ACUTE PSYCHOSIS 126 0.0509
78 WRONG PATIENT RECEIVED PRODUCT 149 0.0509
79 TALIPES 158 0.0508
80 STARING 121 0.0500
81 ABORTION SPONTANEOUS 1953 0.0487
82 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1240 0.0481
83 PSYCHOMOTOR SKILLS IMPAIRED 121 0.0461
84 VENTRICULAR SEPTAL DEFECT 264 0.0461
85 NYSTAGMUS 238 0.0448
86 LOW BIRTH WEIGHT BABY 353 0.0444
87 TONGUE BITING 91 0.0441
88 PSYCHOMOTOR RETARDATION 124 0.0441
89 AGGRESSION 2185 0.0436
90 PATENT DUCTUS ARTERIOSUS 172 0.0433
91 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 115 0.0432
92 MATERNAL EXPOSURE BEFORE PREGNANCY 295 0.0431
93 MATERNAL DRUGS AFFECTING FOETUS 331 0.0431
94 MATERNAL EXPOSURE DURING PREGNANCY 3822 0.0428
95 TOXIC ENCEPHALOPATHY 216 0.0426
96 ENCEPHALOPATHY 1044 0.0425
97 CYTOKINE RELEASE SYNDROME 851 0.0424
98 ACCIDENTAL DEATH 78 0.0419
99 METABOLIC ENCEPHALOPATHY 122 0.0406
100 STUPOR 130 0.0404
101 PERSECUTORY DELUSION 100 0.0401
102 EXPOSURE VIA BREAST MILK 158 0.0396
103 CHOLESTATIC LIVER INJURY 88 0.0395
104 MATERNAL EXPOSURE DURING BREAST FEEDING 160 0.0394
105 AFFECTIVE DISORDER 309 0.0393
106 ABORTION INDUCED 366 0.0388
107 BRAIN OEDEMA 486 0.0384
108 FOETAL EXPOSURE DURING PREGNANCY 3125 0.0384
109 TOXIC EPIDERMAL NECROLYSIS 577 0.0380
110 ATRIAL SEPTAL DEFECT 314 0.0375
111 AMMONIA INCREASED 190 0.0372
112 ANGER 1232 0.0364
113 HYDROCEPHALUS 197 0.0361
114 BRAIN ABSCESS 91 0.0359
115 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 343 0.0359
116 CEREBRAL ATROPHY 143 0.0358
117 HYPERNATRAEMIA 178 0.0357
118 DRUG RESISTANCE 911 0.0354
119 BRAIN NEOPLASM 323 0.0351
120 EYE MOVEMENT DISORDER 234 0.0341
121 RHABDOMYOLYSIS 1421 0.0340
122 LANGUAGE DISORDER 73 0.0337
123 RASH MORBILLIFORM 93 0.0335
124 HOSTILITY 85 0.0334
125 SLOW SPEECH 81 0.0333
126 LICHENOID KERATOSIS 76 0.0332
127 RESPIRATORY ACIDOSIS 126 0.0320
128 CLONUS 87 0.0318
129 SUICIDAL BEHAVIOUR 131 0.0315
130 FOETAL GROWTH RESTRICTION 191 0.0314
131 BRAIN HERNIATION 93 0.0311
132 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 101 0.0311
133 DIABETES INSIPIDUS 74 0.0307
134 POTENTIATING DRUG INTERACTION 103 0.0307
135 ENDOTRACHEAL INTUBATION 86 0.0306
136 STEVENS-JOHNSON SYNDROME 682 0.0306
137 PERSONALITY DISORDER 80 0.0305
138 DEVELOPMENTAL DELAY 274 0.0303
139 PERSONALITY CHANGE 278 0.0299
140 APHASIA 900 0.0298
141 DRUG LEVEL DECREASED 302 0.0296
142 HEMIPARESIS 502 0.0296
143 HYPOTONIA 294 0.0294
144 BRADYPNOEA 78 0.0289
145 DEPRESSIVE SYMPTOM 101 0.0286
146 HEPATOCELLULAR INJURY 405 0.0285
147 AUTONOMIC NERVOUS SYSTEM IMBALANCE 83 0.0284
148 DRUG LEVEL INCREASED 467 0.0282
149 ENCEPHALITIS 195 0.0282
150 PREMATURE DELIVERY 448 0.0281
151 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 107 0.0280
152 PNEUMONIA ASPIRATION 698 0.0279
153 ABNORMAL BEHAVIOUR 1102 0.0278
154 COORDINATION ABNORMAL 387 0.0277
155 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 206 0.0274
156 RHINOVIRUS INFECTION 106 0.0272
157 IRRITABILITY 1625 0.0270
158 COGNITIVE DISORDER 1257 0.0269
159 HYPERTRANSAMINASAEMIA 187 0.0269
160 BRADYPHRENIA 173 0.0265
161 COMMUNICATION DISORDER 101 0.0264
162 PSYCHOTIC DISORDER 780 0.0264
163 IMPULSIVE BEHAVIOUR 99 0.0264
164 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 134 0.0261
165 CAESAREAN SECTION 302 0.0259
166 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 201 0.0258
167 HYPOVENTILATION 84 0.0258
168 NEONATAL RESPIRATORY DISTRESS SYNDROME 91 0.0257
169 MENTAL STATUS CHANGES 713 0.0256
170 CLUMSINESS 70 0.0256
171 PARKINSONISM 249 0.0255
172 APNOEA 197 0.0253
173 METASTASES TO CENTRAL NERVOUS SYSTEM 325 0.0252
174 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 66 0.0252
175 MENINGITIS ASEPTIC 113 0.0251
176 FEELING DRUNK 184 0.0247
177 PRE-ECLAMPSIA 117 0.0246
178 PARAPLEGIA 71 0.0246
179 MIXED LIVER INJURY 74 0.0246
180 EOSINOPHILIA 429 0.0245
181 CRANIOCEREBRAL INJURY 74 0.0244
182 SPEECH DISORDER DEVELOPMENTAL 70 0.0244
183 CYTOLYTIC HEPATITIS 81 0.0244
184 BRAIN NEOPLASM MALIGNANT 109 0.0244
185 PSYCHOMOTOR HYPERACTIVITY 403 0.0243
186 MOOD SWINGS 772 0.0242
187 SCREAMING 153 0.0240
188 ALTERED STATE OF CONSCIOUSNESS 518 0.0239
189 CHOLESTASIS 458 0.0238
190 NEUROTOXICITY 417 0.0238
191 HYPOTHERMIA 237 0.0234
192 CEREBRAL HAEMATOMA 78 0.0232
193 DRUG LEVEL BELOW THERAPEUTIC 128 0.0232
194 PSYCHIATRIC SYMPTOM 170 0.0230
195 DYSPHEMIA 101 0.0230
196 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 95 0.0228
197 HEPATIC CYTOLYSIS 291 0.0228
198 SUBDURAL HAEMATOMA 326 0.0228
199 PREMATURE BABY 684 0.0227
200 HYPOMAGNESAEMIA 314 0.0225
201 AFFECT LABILITY 217 0.0225
202 RASH MACULO-PAPULAR 500 0.0225
203 HALLUCINATION, AUDITORY 357 0.0224
204 ATRIOVENTRICULAR BLOCK COMPLETE 150 0.0224
205 EXPOSURE DURING BREAST FEEDING 74 0.0223
206 AGITATION 1632 0.0222
207 DRUG INTERACTION 3513 0.0221
208 CATATONIA 115 0.0219
209 MAJOR DEPRESSION 159 0.0217
210 HYPONATRAEMIA 1223 0.0217
211 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 222 0.0216
212 DRUG EXPOSURE DURING PREGNANCY 734 0.0216
213 HALLUCINATION, VISUAL 455 0.0215
214 DELIRIUM 747 0.0215
215 SOMNOLENCE 4251 0.0211
216 FACIAL BONES FRACTURE 76 0.0211
217 SEDATION 552 0.0211
218 DEPRESSED LEVEL OF CONSCIOUSNESS 833 0.0210
219 TOXIC SKIN ERUPTION 209 0.0207
220 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1133 0.0206
221 TUBULOINTERSTITIAL NEPHRITIS 386 0.0206
222 ASPIRATION 224 0.0204
223 ACUTE HEPATIC FAILURE 277 0.0203
224 PARANOIA 349 0.0202
225 METABOLIC ACIDOSIS 645 0.0201
226 LYMPHOPENIA 285 0.0201
227 TORSADE DE POINTES 158 0.0201
228 EXPOSURE DURING PREGNANCY 1248 0.0201
229 SOPOR 266 0.0201
230 BRAIN INJURY 201 0.0200
231 BLOOD LACTIC ACID INCREASED 105 0.0199
232 MOOD ALTERED 543 0.0199
233 DYSARTHRIA 748 0.0199
234 THROMBOCYTOPENIA 2216 0.0198
235 DIPLOPIA 512 0.0197
236 INTESTINAL ISCHAEMIA 108 0.0196
237 HEAD INJURY 620 0.0196
238 AUTISM SPECTRUM DISORDER 107 0.0194
239 MULTIPLE ORGAN DYSFUNCTION SYNDROME 548 0.0193
240 DELUSION 298 0.0192
241 MUSCLE TWITCHING 441 0.0191
242 HEMIPLEGIA 159 0.0191
243 CEREBRAL DISORDER 141 0.0190
244 HOMICIDAL IDEATION 77 0.0190
245 CARDIOPULMONARY FAILURE 73 0.0187
246 UNRESPONSIVE TO STIMULI 483 0.0187
247 CEREBRAL HAEMORRHAGE 669 0.0187
248 DROOLING 129 0.0187
249 AGRANULOCYTOSIS 347 0.0187
250 MOTOR DYSFUNCTION 190 0.0186
251 HALLUCINATIONS, MIXED 78 0.0185
252 HEART DISEASE CONGENITAL 65 0.0184
253 GESTATIONAL DIABETES 87 0.0182
254 HYPERTHERMIA 139 0.0182
255 COMA 864 0.0181
256 BRADYKINESIA 107 0.0181
257 ATTENTION DEFICIT HYPERACTIVITY DISORDER 76 0.0180
258 HAEMODYNAMIC INSTABILITY 136 0.0178
259 PRODUCT SUBSTITUTION ISSUE 1026 0.0178
260 DISORIENTATION 705 0.0178
261 PANCYTOPENIA 990 0.0177
262 MALABSORPTION 92 0.0176
263 HYPERTONIA 100 0.0174
264 CENTRAL NERVOUS SYSTEM LESION 239 0.0174
265 GUILLAIN-BARRE SYNDROME 84 0.0173
266 OBSESSIVE-COMPULSIVE DISORDER 139 0.0173
267 HYPERSOMNIA 495 0.0172
268 SPEECH DISORDER 902 0.0172
269 APATHY 251 0.0172
270 ATRIOVENTRICULAR BLOCK FIRST DEGREE 74 0.0171
271 DISTURBANCE IN ATTENTION 907 0.0168
272 VENTRICULAR FIBRILLATION 185 0.0166
273 SINUS BRADYCARDIA 161 0.0166
274 PREMATURE LABOUR 94 0.0166
275 HEPATITIS CHOLESTATIC 100 0.0166
276 INCOHERENT 107 0.0165
277 DYSKINESIA 671 0.0165
278 WRONG PRODUCT ADMINISTERED 111 0.0164
279 AMNESIA 1063 0.0163
280 LEUKOPENIA 815 0.0163
281 MENINGITIS 108 0.0162
282 CONFUSIONAL STATE 2607 0.0161
283 THINKING ABNORMAL 300 0.0161
284 ESCHERICHIA URINARY TRACT INFECTION 68 0.0160
285 VENTRICULAR TACHYCARDIA 264 0.0160
286 SELF-INJURIOUS IDEATION 67 0.0160
287 INTENTIONAL SELF-INJURY 321 0.0159
288 GAMMA-GLUTAMYLTRANSFERASE INCREASED 352 0.0159
289 HYPOKALAEMIA 733 0.0159
290 HEPATITIS ACUTE 103 0.0158
291 BLOOD CREATINE PHOSPHOKINASE INCREASED 456 0.0158
292 VENOOCCLUSIVE LIVER DISEASE 78 0.0158
293 DYSGRAPHIA 104 0.0158
294 MUCOSAL INFLAMMATION 413 0.0158
295 PRESCRIBED OVERDOSE 304 0.0157
296 AUTOIMMUNE HEPATITIS 109 0.0157
297 INTRACRANIAL PRESSURE INCREASED 87 0.0156
298 FAILURE TO THRIVE 81 0.0156
299 ELECTROCARDIOGRAM QT PROLONGED 559 0.0155
300 SUBARACHNOID HAEMORRHAGE 156 0.0153
301 BALANCE DISORDER 1315 0.0152
302 PRODUCT ADMINISTRATION INTERRUPTED 119 0.0151
303 BRADYCARDIA 802 0.0151
304 HAEMORRHAGE INTRACRANIAL 225 0.0150
305 HYPOALBUMINAEMIA 117 0.0150
306 ILEUS PARALYTIC 67 0.0150
307 DRUG ERUPTION 266 0.0150
308 ELECTROLYTE IMBALANCE 174 0.0150
309 HYPOCALCAEMIA 283 0.0149
310 PETECHIAE 156 0.0149
311 LETHARGY 855 0.0148
312 KLEBSIELLA INFECTION 75 0.0148
313 CEREBRAL ISCHAEMIA 76 0.0148
314 DIABETIC NEUROPATHY 73 0.0147
315 CLOSTRIDIUM DIFFICILE COLITIS 156 0.0147
316 ACUTE RESPIRATORY FAILURE 282 0.0146
317 DERMATITIS EXFOLIATIVE 73 0.0146
318 HYPERBILIRUBINAEMIA 151 0.0146
319 VISUAL FIELD DEFECT 105 0.0145
320 HALLUCINATION 1093 0.0145
321 BLEPHAROSPASM 91 0.0144
322 RESPIRATORY DEPRESSION 177 0.0144
323 SUICIDAL IDEATION 1318 0.0144
324 NORMAL NEWBORN 78 0.0143
325 TRANSAMINASES INCREASED 318 0.0143
326 RESPIRATORY FAILURE 1042 0.0143
327 SUICIDE ATTEMPT 859 0.0142
328 ATRIOVENTRICULAR BLOCK 109 0.0141
329 INCONTINENCE 149 0.0141
330 SALIVARY HYPERSECRETION 141 0.0141
331 NEUROLEPTIC MALIGNANT SYNDROME 167 0.0141
332 CONCUSSION 109 0.0141
333 RESPIRATORY DISTRESS 386 0.0140
334 HOSPICE CARE 137 0.0139
335 HYPOGAMMAGLOBULINAEMIA 91 0.0138
336 FLUID INTAKE REDUCED 69 0.0138
337 BLOOD SODIUM DECREASED 259 0.0137
338 VITAMIN D DEFICIENCY 134 0.0137
339 MANIA 225 0.0137
340 RESTLESSNESS 498 0.0136
341 ERYTHEMA MULTIFORME 126 0.0135
342 DRUG-INDUCED LIVER INJURY 419 0.0133
343 TREATMENT NONCOMPLIANCE 723 0.0132
344 INTENTIONAL OVERDOSE 847 0.0132
345 DERMATITIS BULLOUS 95 0.0131
346 URINARY INCONTINENCE 387 0.0130
347 TOXICITY TO VARIOUS AGENTS 2198 0.0130
348 REFUSAL OF TREATMENT BY PATIENT 85 0.0130
349 PRODUCT AVAILABILITY ISSUE 295 0.0129
350 HAEMORRHAGIC STROKE 101 0.0129
351 CIRCULATORY COLLAPSE 220 0.0129
352 LEUKOCYTOSIS 232 0.0128
353 HEPATITIS 328 0.0128
354 HEPATIC ENCEPHALOPATHY 119 0.0127
355 THROMBOTIC MICROANGIOPATHY 124 0.0127
356 MUSCLE RIGIDITY 152 0.0127
357 MEMORY IMPAIRMENT 1741 0.0127
358 THERAPY PARTIAL RESPONDER 197 0.0126
359 ATELECTASIS 122 0.0126
360 BLOOD ALBUMIN DECREASED 100 0.0126
361 TRICUSPID VALVE INCOMPETENCE 100 0.0126
362 COAGULOPATHY 209 0.0125
363 FOETAL DEATH 65 0.0125
364 FRUSTRATION TOLERANCE DECREASED 101 0.0125
365 NEUTROPENIC SEPSIS 89 0.0124
366 HYPOPHOSPHATAEMIA 92 0.0124
367 THERAPY NON-RESPONDER 556 0.0124
368 PRODUCT PREPARATION ISSUE 81 0.0123
369 CRYING 446 0.0123
370 METABOLIC DISORDER 71 0.0122
371 JOINT DISLOCATION 129 0.0122
372 ACIDOSIS 93 0.0122
373 RASH PUSTULAR 88 0.0121
374 SCOLIOSIS 74 0.0119
375 PSEUDOMONAS INFECTION 102 0.0119
376 CARDIAC ARREST 982 0.0119
377 MENTAL DISORDER 516 0.0118
378 NEUROLOGICAL SYMPTOM 67 0.0117
379 ISCHAEMIC STROKE 209 0.0117
380 LOSS OF CONSCIOUSNESS 1499 0.0117
381 PEMPHIGOID 88 0.0116
382 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 96 0.0116
383 FACIAL PARALYSIS 99 0.0116
384 OLIGURIA 72 0.0116
385 SENSORY LOSS 93 0.0115
386 ACUTE KIDNEY INJURY 1765 0.0115
387 ECCHYMOSIS 79 0.0115
388 DEPRESSED MOOD 607 0.0115
389 FALL 3813 0.0114
390 SUDDEN DEATH 121 0.0114
391 BIPOLAR DISORDER 124 0.0114
392 HAEMATOCRIT DECREASED 225 0.0113
393 TREMOR 1881 0.0113
394 MENTAL IMPAIRMENT 274 0.0113
395 DECUBITUS ULCER 92 0.0113
396 HAEMATOMA 292 0.0113
397 INITIAL INSOMNIA 115 0.0112
398 PRODUCT SUPPLY ISSUE 80 0.0112
399 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 99 0.0112
400 THERMAL BURN 79 0.0111
401 OFF LABEL USE 9748 0.0111
402 BACTERAEMIA 132 0.0111
403 LIPASE INCREASED 85 0.0111
404 LACERATION 104 0.0110
405 SINUS TACHYCARDIA 157 0.0110
406 NERVOUS SYSTEM DISORDER 345 0.0110
407 LEFT VENTRICULAR DYSFUNCTION 74 0.0110
408 MALNUTRITION 123 0.0110
409 PRODUCT ADMINISTRATION ERROR 222 0.0110
410 INABILITY TO AFFORD MEDICATION 109 0.0110
411 BODY TEMPERATURE DECREASED 108 0.0110
412 URINARY RETENTION 366 0.0110
413 HYPOXIA 385 0.0109
414 DYSTONIA 212 0.0109
415 RESPIRATORY RATE INCREASED 97 0.0109
416 SEROTONIN SYNDROME 209 0.0109
417 SLEEP APNOEA SYNDROME 207 0.0108
418 OXYGEN SATURATION DECREASED 608 0.0108
419 SEPTIC SHOCK 467 0.0107
420 CONDITION AGGRAVATED 3263 0.0107
421 DEPRESSION 2434 0.0107
422 SLEEP DISORDER 741 0.0105
423 CYANOSIS 165 0.0105
424 LYMPHOCYTE COUNT DECREASED 185 0.0105
425 PURPURA 92 0.0104
426 DYSPHAGIA 977 0.0103
427 HAEMOLYTIC ANAEMIA 92 0.0103
428 TREATMENT FAILURE 850 0.0102
429 ALANINE AMINOTRANSFERASE INCREASED 628 0.0102
430 MIOSIS 82 0.0102
431 HEPATOTOXICITY 227 0.0102
432 URINE OUTPUT DECREASED 89 0.0102
433 HICCUPS 83 0.0101
434 CARDIOTOXICITY 90 0.0101
435 POLYNEUROPATHY 120 0.0100
436 HERPES SIMPLEX 65 0.0100
437 BLOOD ALKALINE PHOSPHATASE INCREASED 248 0.0100
438 BLOOD MAGNESIUM DECREASED 86 0.0100
439 PAROSMIA 75 0.0099
440 GAIT DISTURBANCE 1898 0.0099
441 EMOTIONAL DISORDER 304 0.0099
442 BONE MARROW FAILURE 200 0.0098
443 NEOPLASM 112 0.0097
444 PARALYSIS 139 0.0097
445 JAUNDICE 261 0.0097
446 MOVEMENT DISORDER 311 0.0097
447 NEUTROPENIA 1314 0.0097
448 OVERDOSE 2081 0.0096
449 ACUTE RESPIRATORY DISTRESS SYNDROME 170 0.0096
450 GENERAL PHYSICAL HEALTH DETERIORATION 1107 0.0096
451 DRUG INEFFECTIVE 12564 0.0095
452 RESPIRATORY SYNCYTIAL VIRUS INFECTION 83 0.0095
453 MUSCLE SPASTICITY 117 0.0095
454 PHOTOSENSITIVITY REACTION 157 0.0095
455 ACCIDENTAL OVERDOSE 347 0.0095
456 PRODUCT TASTE ABNORMAL 128 0.0094
457 ANAL INCONTINENCE 85 0.0094
458 HYPOKINESIA 137 0.0094
459 UROSEPSIS 87 0.0094
460 HYPOTENSION 1881 0.0094
461 DISSEMINATED INTRAVASCULAR COAGULATION 132 0.0094
462 EOSINOPHIL COUNT INCREASED 78 0.0094
463 ASPARTATE AMINOTRANSFERASE INCREASED 497 0.0093
464 HEPATIC FAILURE 282 0.0093
465 SEPSIS 1042 0.0093
466 HEPATIC FUNCTION ABNORMAL 348 0.0093
467 TACHYCARDIA 828 0.0093
468 LIVER INJURY 228 0.0093
469 MITRAL VALVE INCOMPETENCE 105 0.0093
470 MYDRIASIS 119 0.0093
471 EUPHORIC MOOD 95 0.0093
472 CARDIO-RESPIRATORY ARREST 387 0.0092
473 DISEASE PROGRESSION 1091 0.0092
474 EJECTION FRACTION DECREASED 143 0.0092
475 SKIN LACERATION 100 0.0092
476 CYTOPENIA 112 0.0091
477 PHOTOPHOBIA 172 0.0091
478 LIVER FUNCTION TEST ABNORMAL 265 0.0091
479 DIFFUSE LARGE B-CELL LYMPHOMA 70 0.0091
480 HYPOPHAGIA 232 0.0091
481 ORTHOSTATIC HYPOTENSION 158 0.0091
482 PRESCRIBED UNDERDOSE 181 0.0091
483 FEEDING DISORDER 184 0.0091
484 POLYURIA 74 0.0090
485 POOR QUALITY SLEEP 194 0.0090
486 DECREASED APPETITE 2086 0.0090
487 RESPIRATORY ARREST 247 0.0090
488 PRODUCT PRESCRIBING ERROR 213 0.0089
489 ILEUS 111 0.0089
490 MEDICATION ERROR 496 0.0089
491 PANIC ATTACK 325 0.0089
492 IRON DEFICIENCY ANAEMIA 82 0.0089
493 URINARY TRACT INFECTION 1515 0.0089
494 PYREXIA 3073 0.0089
495 PRODUCT ODOUR ABNORMAL 93 0.0089
496 EATING DISORDER 189 0.0089
497 MOUTH HAEMORRHAGE 65 0.0089
498 PLATELET COUNT DECREASED 941 0.0088
499 HYDRONEPHROSIS 66 0.0088
500 VERTIGO 537 0.0088
501 TROPONIN INCREASED 67 0.0088
502 DERMATITIS ALLERGIC 110 0.0087
503 MUSCULAR WEAKNESS 990 0.0087
504 MENINGIOMA 136 0.0087
505 SYNCOPE 870 0.0087
506 PULMONARY HAEMORRHAGE 68 0.0087
507 TACHYPNOEA 118 0.0087
508 RED BLOOD CELL COUNT DECREASED 248 0.0087
509 MICTURITION URGENCY 99 0.0087
510 SENSORY DISTURBANCE 139 0.0087
511 SHOCK 199 0.0086
512 MIDDLE INSOMNIA 161 0.0086
513 HEPATIC STEATOSIS 160 0.0086
514 DRUG TOXICITY 117 0.0086
515 HYPERCALCAEMIA 106 0.0086
516 BODY TEMPERATURE INCREASED 175 0.0086
517 SUPRAVENTRICULAR TACHYCARDIA 82 0.0086
518 FEBRILE NEUTROPENIA 568 0.0086
519 HAEMATEMESIS 216 0.0085
520 FEAR 229 0.0085
521 PANCREATITIS ACUTE 191 0.0085
522 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 599 0.0084
523 DEMENTIA 235 0.0084
524 ADRENAL INSUFFICIENCY 102 0.0084
525 LUNG INFILTRATION 74 0.0084
526 ROAD TRAFFIC ACCIDENT 350 0.0084
527 NO THERAPEUTIC RESPONSE 102 0.0084
528 POISONING 105 0.0083
529 REBOUND EFFECT 94 0.0083
530 ADVERSE DRUG REACTION 746 0.0083
531 BLOOD CALCIUM DECREASED 93 0.0083
532 RENAL TUBULAR NECROSIS 81 0.0082
533 NEOPLASM PROGRESSION 287 0.0082
534 GASTROENTERITIS VIRAL 149 0.0082
535 LIVER FUNCTION TEST INCREASED 177 0.0082
536 PNEUMONIA 2663 0.0082
537 WOUND INFECTION 90 0.0082
538 CLOSTRIDIUM DIFFICILE INFECTION 179 0.0082
539 INCREASED TENDENCY TO BRUISE 75 0.0081
540 VITAMIN D DECREASED 69 0.0081
541 INTENTIONAL PRODUCT MISUSE 704 0.0080
542 PRODUCT USE ISSUE 1507 0.0080
543 LOSS OF LIBIDO 72 0.0080
544 INTERNATIONAL NORMALISED RATIO INCREASED 228 0.0080
545 NEUTROPHIL COUNT DECREASED 325 0.0080
546 UPPER LIMB FRACTURE 158 0.0079
547 MULTI-ORGAN FAILURE 137 0.0079
548 LIVE BIRTH 66 0.0079
549 DEHYDRATION 1051 0.0079
550 TRANSIENT ISCHAEMIC ATTACK 265 0.0078
551 INSURANCE ISSUE 120 0.0078
552 AKATHISIA 107 0.0078
553 GINGIVAL BLEEDING 107 0.0078
554 HEPATOMEGALY 77 0.0078
555 IMPAIRED DRIVING ABILITY 89 0.0078
556 PNEUMONITIS 213 0.0078
557 NEUTROPHIL COUNT INCREASED 80 0.0078
558 CHOLECYSTITIS 93 0.0078
559 VENTRICULAR EXTRASYSTOLES 81 0.0078
560 DEVICE RELATED INFECTION 120 0.0078
561 BLOOD LACTATE DEHYDROGENASE INCREASED 123 0.0078
562 PANCREATITIS 410 0.0077
563 ANXIETY 2204 0.0077
564 PERICARDIAL EFFUSION 179 0.0077
565 HYPERGLYCAEMIA 282 0.0077
566 GENERALISED OEDEMA 95 0.0077
567 DRUG INTOLERANCE 741 0.0077
568 INTESTINAL PERFORATION 86 0.0077
569 CEREBRAL INFARCTION 187 0.0076
570 BEDRIDDEN 100 0.0076
571 VIRAL INFECTION 253 0.0076
572 HOSPITALISATION 1167 0.0076
573 EAR INFECTION 202 0.0076
574 INSOMNIA 2020 0.0076
575 CYTOMEGALOVIRUS INFECTION 126 0.0076
576 WEIGHT DECREASED 2112 0.0076
577 LYMPHADENOPATHY 267 0.0075
578 DYSSTASIA 220 0.0075
579 FACE OEDEMA 127 0.0075
580 END STAGE RENAL DISEASE 137 0.0075
581 DISEASE RECURRENCE 356 0.0075
582 SKIN LESION 205 0.0075
583 COMPLETED SUICIDE 622 0.0075
584 HYPOGLYCAEMIA 360 0.0074
585 CARDIOMEGALY 91 0.0074
586 HYPERTHYROIDISM 107 0.0074
587 C-REACTIVE PROTEIN INCREASED 268 0.0074
588 SLUGGISHNESS 75 0.0073
589 HEPATIC ENZYME INCREASED 501 0.0073
590 FRACTURE 139 0.0073
591 PRODUCT DISTRIBUTION ISSUE 68 0.0073
592 ADVERSE REACTION 97 0.0073
593 DIZZINESS 3642 0.0073
594 FATIGUE 5672 0.0073
595 UNINTENDED PREGNANCY 76 0.0073
596 CEREBROVASCULAR ACCIDENT 1231 0.0073
597 IMPAIRED WORK ABILITY 155 0.0072
598 STAPHYLOCOCCAL INFECTION 239 0.0072
599 SCHIZOPHRENIA 88 0.0072
600 RESPIRATORY TRACT INFECTION 188 0.0072
601 ORAL CANDIDIASIS 95 0.0072
602 PRODUCT USE IN UNAPPROVED INDICATION 1788 0.0072
603 RENAL FAILURE 957 0.0072
604 DEEP VEIN THROMBOSIS 465 0.0071
605 BLOOD POTASSIUM DECREASED 215 0.0071
606 NO ADVERSE EVENT 1294 0.0071
607 NEPHROPATHY TOXIC 80 0.0071
608 JOINT INJURY 152 0.0071
609 ANAEMIA 1356 0.0071
610 CARDIOGENIC SHOCK 102 0.0071
611 CARDIOMYOPATHY 105 0.0071
612 POISONING DELIBERATE 67 0.0071
613 CANDIDA INFECTION 119 0.0070
614 SKIN REACTION 99 0.0070
615 THERAPY CHANGE 69 0.0070
616 LIGAMENT SPRAIN 69 0.0070
617 DENTAL CARIES 77 0.0070
618 VOMITING 3267 0.0069
619 LACTIC ACIDOSIS 225 0.0069
620 OSTEOPENIA 105 0.0069
621 BLISTER 388 0.0069
622 NIGHTMARE 239 0.0069
623 DISABILITY 136 0.0069
624 RESTLESS LEGS SYNDROME 125 0.0069
625 NEPHROLITHIASIS 315 0.0069
626 ACCIDENT 82 0.0069
627 FOOT FRACTURE 130 0.0069
628 RASH ERYTHEMATOUS 326 0.0068
629 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 484 0.0068
630 RASH GENERALISED 176 0.0068
631 MALIGNANT NEOPLASM PROGRESSION 695 0.0068
632 ASTHENIA 2548 0.0068
633 PNEUMOCYSTIS JIROVECII PNEUMONIA 68 0.0068
634 DRUG WITHDRAWAL SYNDROME NEONATAL 100 0.0067
635 SEASONAL ALLERGY 95 0.0067
636 NERVOUSNESS 350 0.0067
637 DECREASED ACTIVITY 72 0.0067
638 DRUG DISPENSING ERROR 102 0.0067
639 GAIT INABILITY 223 0.0067
640 RESPIRATORY DISORDER 199 0.0066
641 MIGRAINE 630 0.0066
642 NEURALGIA 160 0.0066
643 COLITIS 249 0.0066
644 BLOOD TRIGLYCERIDES INCREASED 116 0.0066
645 PERIPHERAL COLDNESS 90 0.0065
646 TOOTH FRACTURE 72 0.0065
647 HYPERLIPIDAEMIA 78 0.0065
648 WHITE BLOOD CELL COUNT DECREASED 705 0.0065
649 HYPOTHYROIDISM 207 0.0065
650 PRODUCT DOSE OMISSION 422 0.0065
651 FOOT DEFORMITY 71 0.0064
652 BLOOD BILIRUBIN INCREASED 173 0.0064
653 TRANSFUSION 67 0.0064
654 HAEMOGLOBIN DECREASED 655 0.0064
655 BLOOD CREATININE INCREASED 416 0.0064
656 PHARYNGITIS 79 0.0064
657 CHOKING 124 0.0063
658 POST PROCEDURAL COMPLICATION 122 0.0063
659 RIB FRACTURE 130 0.0063
660 UNEVALUABLE EVENT 477 0.0063
661 PULMONARY CONGESTION 83 0.0063
662 PLEURAL EFFUSION 383 0.0063
663 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 302 0.0063
664 HEAD DISCOMFORT 111 0.0063
665 LIMB INJURY 170 0.0063
666 PALLOR 170 0.0062
667 HYPERKALAEMIA 219 0.0062
668 WEIGHT INCREASED 1396 0.0062
669 INCREASED APPETITE 119 0.0062
670 THERAPY INTERRUPTED 445 0.0062
671 PRODUCT USE COMPLAINT 98 0.0062
672 EPISTAXIS 462 0.0062
673 SPLENOMEGALY 72 0.0061
674 WITHDRAWAL SYNDROME 258 0.0061
675 DYSURIA 226 0.0061
676 LIVER DISORDER 272 0.0061
677 MOUTH ULCERATION 129 0.0061
678 THYROID DISORDER 94 0.0061
679 CYSTITIS 194 0.0061
680 ABNORMAL DREAMS 168 0.0061
681 ABASIA 150 0.0061
682 STOMATITIS 368 0.0061
683 CONTUSION 583 0.0060
684 ANOREXIA 78 0.0060
685 HEADACHE 3774 0.0060
686 TASTE DISORDER 122 0.0060
687 PULMONARY EMBOLISM 566 0.0059
688 HEART RATE DECREASED 209 0.0059
689 WHITE BLOOD CELL COUNT INCREASED 228 0.0059
690 LOWER LIMB FRACTURE 114 0.0059
691 BLOOD UREA INCREASED 99 0.0059
692 OEDEMA 320 0.0059
693 GASTROENTERITIS 86 0.0059
694 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101 0.0059
695 SPINAL FRACTURE 118 0.0059
696 INTERSTITIAL LUNG DISEASE 285 0.0059
697 BRAIN FOG 92 0.0059
698 CHRONIC KIDNEY DISEASE 446 0.0059
699 HAEMATURIA 201 0.0059
700 POLLAKIURIA 244 0.0058
701 NERVE INJURY 65 0.0058
702 BACTERIAL INFECTION 109 0.0058
703 CONSTIPATION 1270 0.0058
704 RASH 2535 0.0058
705 ARRHYTHMIA 275 0.0058
706 ORAL PAIN 130 0.0058
707 BLOOD COUNT ABNORMAL 88 0.0058
708 RENAL FAILURE ACUTE 246 0.0058
709 OBESITY 92 0.0058
710 RETCHING 123 0.0058
711 PRODUCT DOSE OMISSION ISSUE 1690 0.0057
712 PNEUMOTHORAX 91 0.0057
713 GASTRITIS 151 0.0057
714 FEELING ABNORMAL 1369 0.0057
715 OSTEOPOROSIS 235 0.0057
716 INTENTIONAL PRODUCT USE ISSUE 499 0.0057
717 SECRETION DISCHARGE 71 0.0057
718 INFLUENZA LIKE ILLNESS 464 0.0056
719 DRUG ABUSE 469 0.0056
720 CHROMATURIA 127 0.0056
721 MUSCLE TIGHTNESS 91 0.0056
722 WOUND 157 0.0056
723 ERECTILE DYSFUNCTION 144 0.0056
724 RENAL IMPAIRMENT 471 0.0056
725 COMPLICATION ASSOCIATED WITH DEVICE 81 0.0056
726 ANKLE FRACTURE 86 0.0056
727 ACTIVITIES OF DAILY LIVING IMPAIRED 110 0.0055
728 MOBILITY DECREASED 399 0.0055
729 UPPER RESPIRATORY TRACT INFECTION 256 0.0055
730 HYPOAESTHESIA 829 0.0055
731 WRIST FRACTURE 66 0.0055
732 ECONOMIC PROBLEM 83 0.0055
733 THERAPEUTIC RESPONSE UNEXPECTED 245 0.0055
734 MULTIPLE SCLEROSIS 261 0.0055
735 PARAESTHESIA 855 0.0054
736 UNDERDOSE 395 0.0054
737 ANGIOEDEMA 239 0.0054
738 BLOOD PRESSURE DECREASED 356 0.0054
739 IMPAIRED QUALITY OF LIFE 77 0.0054
740 IMPAIRED GASTRIC EMPTYING 73 0.0053
741 SKIN DISCOLOURATION 246 0.0053
742 VISION BLURRED 735 0.0053
743 EAR PAIN 104 0.0053
744 HAEMORRHOIDS 104 0.0053
745 PRODUCT DISPENSING ERROR 116 0.0053
746 PRODUCT PRESCRIBING ISSUE 116 0.0053
747 INFECTION 770 0.0053
748 SWOLLEN TONGUE 166 0.0053
749 FEELING JITTERY 101 0.0053
750 IMMUNODEFICIENCY 79 0.0053
751 CONJUNCTIVITIS 98 0.0053
752 ATRIAL FIBRILLATION 514 0.0053
753 INTERVERTEBRAL DISC PROTRUSION 115 0.0053
754 DRUG PRESCRIBING ERROR 101 0.0053
755 PLATELET COUNT INCREASED 68 0.0052
756 RECTAL HAEMORRHAGE 224 0.0052
757 ANHEDONIA 137 0.0052
758 NEUROPATHY PERIPHERAL 495 0.0052
759 CELLULITIS 262 0.0052
760 GASTROOESOPHAGEAL REFLUX DISEASE 416 0.0052
761 HIP FRACTURE 166 0.0052
762 DIARRHOEA 3311 0.0051
763 VISUAL ACUITY REDUCED 170 0.0051
764 FULL BLOOD COUNT DECREASED 103 0.0051
765 VISUAL IMPAIRMENT 631 0.0051
766 PULMONARY OEDEMA 228 0.0051
767 ABSCESS 81 0.0051
768 OEDEMA PERIPHERAL 618 0.0051
769 METASTASES TO BONE 83 0.0051
770 RASH PRURITIC 273 0.0050
771 PULMONARY MASS 75 0.0050
772 BLOOD PRESSURE SYSTOLIC INCREASED 98 0.0050
773 HYPERTENSION 1063 0.0050
774 NECK PAIN 280 0.0050
775 EXTRAPYRAMIDAL DISORDER 124 0.0050
776 DRUG DOSE OMISSION 824 0.0050
777 BLOOD TEST ABNORMAL 70 0.0050
778 SWELLING FACE 322 0.0049
779 CHOLELITHIASIS 162 0.0049
780 FUNGAL INFECTION 164 0.0049
781 SYSTEMIC LUPUS ERYTHEMATOSUS 174 0.0049
782 PROTEINURIA 93 0.0049
783 THERAPY CESSATION 251 0.0049
784 RASH PAPULAR 109 0.0049
785 BLINDNESS 196 0.0048
786 SCAR 82 0.0048
787 HEART RATE INCREASED 473 0.0048
788 HAEMOPTYSIS 133 0.0048
789 METASTASES TO LIVER 83 0.0047
790 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 110 0.0047
791 MULTIPLE SCLEROSIS RELAPSE 323 0.0047
792 SURGERY 276 0.0047
793 GASTROINTESTINAL HAEMORRHAGE 393 0.0047
794 ADVERSE EVENT 433 0.0047
795 UPPER GASTROINTESTINAL HAEMORRHAGE 79 0.0047
796 ASCITES 138 0.0047
797 OSTEOMYELITIS 85 0.0047
798 AGEUSIA 117 0.0047
799 BASAL CELL CARCINOMA 73 0.0047
800 LUNG DISORDER 229 0.0047
801 GASTROINTESTINAL DISORDER 418 0.0047
802 HEPATIC CIRRHOSIS 87 0.0046
803 NAUSEA 3659 0.0046
804 CHILLS 541 0.0046
805 PULMONARY HYPERTENSION 96 0.0046
806 BLOOD PRESSURE FLUCTUATION 110 0.0046
807 ABDOMINAL PAIN 1059 0.0045
808 MUSCLE SPASMS 830 0.0045
809 INFLUENZA 504 0.0045
810 BLOOD PRESSURE INCREASED 686 0.0045
811 KIDNEY INFECTION 88 0.0045
812 BLOOD URINE PRESENT 85 0.0045
813 LUNG INFECTION 69 0.0044
814 DRUG ADMINISTRATION ERROR 136 0.0044
815 FEMUR FRACTURE 137 0.0044
816 THIRST 79 0.0044
817 INTENTIONAL DOSE OMISSION 126 0.0044
818 BRONCHITIS 327 0.0044
819 CARDIAC FAILURE 353 0.0044
820 LIP SWELLING 146 0.0044
821 DYSPHONIA 256 0.0044
822 THROMBOSIS 352 0.0044
823 THERAPEUTIC RESPONSE DECREASED 264 0.0043
824 MELAENA 95 0.0043
825 HYPOAESTHESIA ORAL 65 0.0043
826 BLOOD CHOLESTEROL INCREASED 201 0.0043
827 BONE DISORDER 78 0.0043
828 PRODUCTIVE COUGH 204 0.0043
829 TINNITUS 196 0.0043
830 ABDOMINAL DISTENSION 445 0.0043
831 HAEMATOCHEZIA 234 0.0042
832 INJURY 298 0.0042
833 WRONG TECHNIQUE IN DRUG USAGE PROCESS 154 0.0042
834 OROPHARYNGEAL PAIN 390 0.0042
835 MUSCULOSKELETAL STIFFNESS 369 0.0042
836 FIBROMYALGIA 102 0.0042
837 HYPERSENSITIVITY 778 0.0042
838 COUGH 1168 0.0042
839 HAEMORRHAGE 435 0.0042
840 ALOPECIA 813 0.0041
841 DYSPNOEA EXERTIONAL 155 0.0041
842 HYPERHIDROSIS 530 0.0041
843 MALAISE 1804 0.0041
844 PRESYNCOPE 100 0.0041
845 TOOTHACHE 74 0.0041
846 MULTIPLE FRACTURES 67 0.0041
847 CHEST PAIN 755 0.0041
848 SKIN ULCER 105 0.0041
849 TOOTH DISORDER 90 0.0040
850 ECZEMA 211 0.0040
851 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 118 0.0040
852 COLD SWEAT 71 0.0040
853 DRUG EFFECT INCOMPLETE 146 0.0040
854 LIMB DISCOMFORT 124 0.0040
855 LACRIMATION INCREASED 121 0.0040
856 BACK PAIN 930 0.0040
857 ERYTHEMA 822 0.0040
858 SKIN EXFOLIATION 337 0.0040
859 TYPE 2 DIABETES MELLITUS 134 0.0040
860 INTESTINAL OBSTRUCTION 149 0.0039
861 EYE SWELLING 145 0.0039
862 PAIN IN JAW 110 0.0039
863 NASOPHARYNGITIS 709 0.0038
864 DIABETES MELLITUS 293 0.0038
865 ILLNESS 395 0.0038
866 DEATH 3289 0.0038
867 PERIPHERAL SWELLING 587 0.0038
868 HEART RATE IRREGULAR 86 0.0038
869 ILL-DEFINED DISORDER 231 0.0038
870 MUSCULOSKELETAL DISORDER 72 0.0038
871 SKIN DISORDER 126 0.0038
872 ERUCTATION 73 0.0038
873 FEELING COLD 105 0.0038
874 RASH MACULAR 131 0.0037
875 ORAL HERPES 73 0.0037
876 URTICARIA 625 0.0037
877 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 194 0.0037
878 RENAL DISORDER 173 0.0037
879 EYE DISORDER 122 0.0037
880 FLATULENCE 210 0.0037
881 PALPITATIONS 433 0.0037
882 COVID-19 647 0.0037
883 GLAUCOMA 71 0.0037
884 SKIN FISSURES 72 0.0037
885 ANAPHYLACTIC REACTION 203 0.0037
886 MUSCULOSKELETAL PAIN 192 0.0037
887 DRY MOUTH 297 0.0037
888 HERPES ZOSTER 210 0.0037
889 EYE PAIN 205 0.0036
890 MYALGIA 615 0.0036
891 GASTRIC DISORDER 124 0.0036
892 RHINORRHOEA 233 0.0036
893 GASTRIC ULCER 68 0.0036
894 DYSPNOEA 2025 0.0036
895 TOOTH LOSS 74 0.0036
896 PRURITUS 1367 0.0036
897 ABDOMINAL PAIN UPPER 730 0.0035
898 INFLAMMATION 182 0.0035
899 BLOOD PRESSURE ABNORMAL 70 0.0035
900 DERMATITIS 73 0.0035
901 SKIN CANCER 74 0.0034
902 PRURITUS GENERALISED 74 0.0034
903 RENAL INJURY 101 0.0034
904 DYSPEPSIA 334 0.0034
905 SWELLING 317 0.0034
906 INCORRECT DOSE ADMINISTERED 770 0.0034
907 DIABETIC KETOACIDOSIS 81 0.0034
908 FAECES DISCOLOURED 73 0.0034
909 DYSGEUSIA 250 0.0034
910 INFUSION RELATED REACTION 223 0.0034
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 605 0.0034
912 TARDIVE DYSKINESIA 94 0.0033
913 LABORATORY TEST ABNORMAL 98 0.0033
914 IRRITABLE BOWEL SYNDROME 71 0.0033
915 HYPOACUSIS 142 0.0033
916 PAIN 2026 0.0033
917 CATARACT 196 0.0033
918 DRUG EFFECT DECREASED 177 0.0033
919 PRODUCT DOSE OMISSION IN ERROR 93 0.0033
920 CONTRAINDICATED PRODUCT ADMINISTERED 99 0.0033
921 PAIN IN EXTREMITY 962 0.0033
922 DEAFNESS 84 0.0032
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 649 0.0032
924 OSTEOARTHRITIS 135 0.0032
925 LOCALISED INFECTION 77 0.0032
926 WHEEZING 186 0.0031
927 DISCOMFORT 191 0.0031
928 FLUID RETENTION 159 0.0031
929 SINUSITIS 320 0.0031
930 ABDOMINAL DISCOMFORT 523 0.0031
931 GLOSSODYNIA 69 0.0031
932 DIVERTICULITIS 85 0.0031
933 BONE PAIN 179 0.0031
934 NIGHT SWEATS 98 0.0030
935 CARDIOVASCULAR DISORDER 76 0.0030
936 LOWER RESPIRATORY TRACT INFECTION 136 0.0030
937 CARDIAC DISORDER 273 0.0029
938 BLOOD GLUCOSE DECREASED 140 0.0029
939 NASAL CONGESTION 171 0.0029
940 THERAPEUTIC PRODUCT EFFECT DECREASED 130 0.0029
941 MYELOSUPPRESSION 104 0.0029
942 FEELING HOT 177 0.0029
943 DRUG WITHDRAWAL SYNDROME 251 0.0029
944 ABDOMINAL PAIN LOWER 72 0.0028
945 ACUTE MYOCARDIAL INFARCTION 83 0.0028
946 LUNG NEOPLASM MALIGNANT 115 0.0028
947 PRODUCT QUALITY ISSUE 378 0.0028
948 CHEST DISCOMFORT 280 0.0027
949 ANGINA PECTORIS 78 0.0027
950 ARTHRALGIA 1127 0.0027
951 BURNING SENSATION 185 0.0026
952 JOINT STIFFNESS 69 0.0026
953 IMPAIRED HEALING 86 0.0026
954 ANAPHYLACTIC SHOCK 67 0.0026
955 FLUSHING 263 0.0026
956 VAGINAL HAEMORRHAGE 112 0.0026
957 NEOPLASM MALIGNANT 172 0.0026
958 OCULAR HYPERAEMIA 122 0.0026
959 DRY EYE 128 0.0026
960 DRY SKIN 341 0.0026
961 JOINT SWELLING 307 0.0025
962 HOT FLUSH 191 0.0025
963 ACNE 192 0.0025
964 ASTHMA 281 0.0025
965 FREQUENT BOWEL MOVEMENTS 65 0.0024
966 INCORRECT ROUTE OF DRUG ADMINISTRATION 85 0.0024
967 THROAT IRRITATION 106 0.0024
968 PLASMA CELL MYELOMA 92 0.0024
969 BLOOD GLUCOSE INCREASED 443 0.0023
970 ARTHRITIS 184 0.0023
971 CARDIAC FAILURE CONGESTIVE 186 0.0023
972 EMOTIONAL DISTRESS 279 0.0023
973 MYOCARDIAL INFARCTION 382 0.0022
974 EXTRA DOSE ADMINISTERED 80 0.0020
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 65 0.0019
976 EYE IRRITATION 110 0.0019
977 ARTHROPATHY 106 0.0019
978 SKIN IRRITATION 86 0.0019
979 COLITIS ULCERATIVE 76 0.0017
980 INJECTION SITE BRUISING 103 0.0013
981 PSORIASIS 162 0.0012
982 ACCIDENTAL EXPOSURE TO PRODUCT 127 0.0012
983 SKIN BURNING SENSATION 88 0.0012
984 DEVICE ISSUE 110 0.0012
985 DRUG DEPENDENCE 192 0.0012
986 INJECTION SITE REACTION 80 0.0012
987 DEVICE MALFUNCTION 73 0.0010
988 BREAST CANCER 93 0.0010
989 INJECTION SITE SWELLING 74 0.0010
990 INJECTION SITE PAIN 294 0.0010
991 INJECTION SITE ERYTHEMA 115 0.0009
992 INJECTION SITE HAEMORRHAGE 67 0.0008
993 PRODUCT STORAGE ERROR 68 0.0008
994 RHEUMATOID ARTHRITIS 86 0.0008